MedPath

Verinurad

Generic Name
Verinurad
Drug Type
Small Molecule
Chemical Formula
C20H16N2O2S
CAS Number
1352792-74-5
Unique Ingredient Identifier
12WJ62D047

Overview

Verinurad has been used in trials studying the basic science and treatment of Gout, Gout and Hyperuricemia, and Gout and Asymptomatic Hyperuricemia.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2020/09/16
Phase 1
Completed
2020/08/31
Phase 1
Completed
2020/03/30
Phase 2
Completed
2020/02/05
Phase 1
Completed
2019/07/18
Phase 1
Completed
2019/06/19
Phase 2
Completed
2019/02/11
Phase 1
Completed
2017/10/20
Phase 2
Completed
2017/04/18
Phase 2
Completed
2014/12/17
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath